|
Sign In to gain access to subscriptions and/or personal tools.
|
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases
R J Hayes
MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK, richard.hayes{at}lshtm.ac.uk
N DE Alexander
MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
S Bennett
MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
S N Cousens
MRC Tropical Epidemiology Group, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
This paper discusses the application of the cluster-randomized trial (CRT) design to evaluate the effectiveness of interventions against infectious diseases. In addition to the usual rationale for this design, there are a number of other advantages that are peculiar to the study of infectious diseases. In particular, CRTs are able to measure the overall effect of an intervention at the population level, capturing both the direct effect of an intervention on an individual's susceptibility to infection, and also the indirect effects due to changes in risks of transmission to other individuals, or to the mass effect or `herd immunity' resulting from intervening in a large proportion of the population.
We briefly review published CRTs of interventions against infectious diseases, most of which have been conducted in the developing countries where such diseases predominate. The focus is on trials in which communities or other large groupings are randomized, and in which impacts on infectious disease incidence or mortality are assessed. We then discuss three issues that are of special relevance to CRTs of infectious diseases. First, issues relating to the definition and size of clusters; secondly, the role of matching or stratification, and the choice of matching factors; and thirdly, the definition of direct and indirect effects of intervention, and methods of assessing these components in a CRT. We conclude by outlining some areas for future research.
Statistical Methods in Medical Research, Vol. 9, No. 2,
95-116 (2000)
DOI: 10.1177/096228020000900203

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Abuya, G. Fegan, Y. Rowa, B. Karisa, S. Ochola, W. Mutemi, and V. Marsh
Impact of Ministry of Health Interventions on Private Medicine Retailer Knowledge and Practices on Anti-Malarial Treatment in Kenya
Am J Trop Med Hyg,
June 1, 2009;
80(6):
905 - 913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. O Aral, J. Blanchard, and J. Lipshutz
STD/HIV prevention intervention: efficacy, effectiveness and population impact
Sex Transm Inf,
October 1, 2008;
84(Suppl_2):
ii1 - ii3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sismanidis, L. H Moulton, H. Ayles, K. Fielding, A. Schaap, N. Beyers, G. Bond, P. Godfrey-Faussett, and R. Hayes
Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial
Clinical Trials,
August 1, 2008;
5(4):
316 - 327.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. van Breukelen, M. J. Candel, and M. P. Berger
Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials
Statistical Methods in Medical Research,
August 1, 2008;
17(4):
439 - 458.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Eldridge, D. Ashby, C. Bennett, M. Wakelin, and G. Feder
Internal and external validity of cluster randomised trials: systematic review of recent trials
BMJ,
April 19, 2008;
336(7649):
876 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Gray, G. M. Williams, Y. Li, H. Chen, R. S. Li, S. J. Forsyth, A. G. Barnett, J. Guo, Z. Feng, and D. P. McManus
A Cluster-Randomized Bovine Intervention Trial against Schistosoma japonicum in the People's Republic of China: Design and Baseline Results
Am J Trop Med Hyg,
November 1, 2007;
77(5):
866 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Roudsari, R. Fowler, and A. Nathens
Intracluster correlation coefficient in multicenter childhood trauma studies
Inj. Prev.,
October 1, 2007;
13(5):
344 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paul, S. Andreassen, E. Tacconelli, A. D. Nielsen, N. Almanasreh, U. Frank, R. Cauda, L. Leibovici, and on behalf of the TREAT Study Group
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial
J. Antimicrob. Chemother.,
December 1, 2006;
58(6):
1238 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G Hudgens, P. B Gilbert, and S. G Self
Endpoints in vaccine trials
Statistical Methods in Medical Research,
April 1, 2004;
13(2):
89 - 114.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Donner and N. Klar
Pitfalls of and Controversies in Cluster Randomization Trials
Am J Public Health,
March 1, 2004;
94(3):
416 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Murray, S. P. Varnell, and J. L. Blitstein
Design and Analysis of Group-Randomized Trials: A Review of Recent Methodological Developments
Am J Public Health,
March 1, 2004;
94(3):
423 - 432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Todd, L. Carpenter, X. Li, J. Nakiyingi, R. Gray, and R. Hayes
The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa
Int. J. Epidemiol.,
October 1, 2003;
32(5):
755 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Halloran and I. M. Longini Jr.
Using Validation Sets for Outcomes and Exposure to Infection in Vaccine Field Studies
Am. J. Epidemiol.,
September 1, 2001;
154(5):
391 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chinn
Statistics for the European Respiratory Journal
Eur. Respir. J.,
August 1, 2001;
18(2):
393 - 401.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|